Stockscreener 앱 받기
3.58
2.19%
-0.08
시간 외 거래:
3.66
0.08
+2.23%
전일 마감가:
$3.66
열려 있는:
$3.68
하루 거래량:
1.20M
Relative Volume:
0.91
시가총액:
$306.41M
수익:
-
순이익/손실:
$-36.95M
주가수익비율:
-4.2619
EPS:
-0.84
순현금흐름:
$-33.46M
1주 성능:
+4.07%
1개월 성능:
+7.83%
6개월 성능:
+3.47%
1년 성능:
-51.88%
1일 변동 폭
$3.415
$3.77
1주일 범위
$3.175
$4.2252
52주 변동 폭
$1.61
$9.50
Larimar Therapeutics Inc Stock (LRMR) Company Profile
명칭
Larimar Therapeutics Inc
전화
844-511-9056
주소
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
LRMR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.58 | 322.68M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 개시 | Truist | Buy |
| 2024-10-16 | 개시 | Oppenheimer | Outperform |
| 2024-10-03 | 개시 | Wedbush | Outperform |
| 2024-10-02 | 개시 | H.C. Wainwright | Buy |
| 2024-09-04 | 개시 | Robert W. Baird | Outperform |
| 2024-04-03 | 개시 | Leerink Partners | Outperform |
| 2023-11-17 | 업그레이드 | Citigroup | Neutral → Buy |
| 2022-10-19 | 개시 | Guggenheim | Buy |
| 2022-02-15 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | 개시 | JMP Securities | Mkt Outperform |
| 2021-02-01 | 개시 | William Blair | Outperform |
모두보기
Larimar Therapeutics Inc 주식(LRMR)의 최신 뉴스
Larimar Therapeutics: Institutional Confidence and Capital-Raising Strategy Signal Conviction in Long-Term Pipeline - AInvest
With 40% stake, Larimar Therapeutics, Inc. (NASDAQ:LRMR) seems to have captured institutional investors' interest - Yahoo Finance
Larimar Therapeutics Aligns with FDA Guidance, Revises Nomlabofusp Submission Timeline - MSN
Larimar Therapeutics Sees Significant Stock Purchase by Director - AInvest
Larimar Therapeutics Stock (LRMR) Opinions on Public Offering Announcement - Quiver Quantitative
Mintz Advises on Larimar Therapeutics’ $69 Million Public Offering - Mintz
Larimar Therapeutics Insider Bought Shares Worth $30,000,000, According to a Recent SEC Filing - MarketScreener
Massive Stock Purchase by Larimar Therapeutics Director! - TipRanks
Larimar therapeutics: Deerfield funds buy $10.8m in shares By Investing.com - Investing.com Canada
Larimar therapeutics: Deerfield funds buy $10.8m in shares - Investing.com India
Larimar Therapeutics stock price target lowered to $10 at Jones Trading - Investing.com Canada
Why is Larimar Therapeutics Inc. stock attracting strong analyst attentionCapitalize on high-growth stocks early - Jammu Links News
What analysts say about Larimar Therapeutics Inc. stockCapitalize on high-yield stocks early - Jammu Links News
What institutional investors are buying Larimar Therapeutics Inc. stockAchieve exceptional returns with expert guidance - Jammu Links News
What catalysts could drive Larimar Therapeutics Inc. stock higher in 2025Build wealth steadily with expert advice - Jammu Links News
How does Larimar Therapeutics Inc. compare to its industry peersBuild a portfolio that withstands market volatility - Jammu Links News
What are analysts’ price targets for Larimar Therapeutics Inc. in the next 12 monthsUnmatched profit potential - Jammu Links News
Should I hold or sell Larimar Therapeutics Inc. stock in 2025Discover stocks with strong growth potential - Jammu Links News
Is Larimar Therapeutics Inc. a good long term investmentCapitalize on market shifts before others do - Jammu Links News
What are the technical indicators suggesting about Larimar Therapeutics Inc.Unlock powerful market insights for success - Jammu Links News
What are Larimar Therapeutics Inc. company’s key revenue driversDiscover breakthrough stocks before the crowd - Jammu Links News
Larimar Therapeutics Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView
Larimar Therapeutics raises $69 million in public offering - Investing.com
Larimar Therapeutics raises $69 million in public offering By Investing.com - Investing.com Nigeria
Larimar Therapeutics Announces $64.4 Million Stock Offering - The Globe and Mail
Why Larimar Therapeutics Inc. is moving todayAutomated AI Forecast with Trading Alerts - Newser
Relative strength of Larimar Therapeutics Inc. in sector analysisSmart Trade Mapping with Entry Details - Newser
Analyzing recovery setups for Larimar Therapeutics Inc. investorsOversold Reversal Picks with Buy Zone - Newser
Larimar Therapeutics Raises $64.4 Million in Stock Offering - AInvest
Short interest data insights for Larimar Therapeutics Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
Larimar Therapeutics Announces Closing of Underwritten - GlobeNewswire
Larimar Therapeutics Announces Closing of Underwritten Public Of - GuruFocus
Larimar Therapeutics Closes $69 Million Public Offering of Common Stock to Support Development of Pipeline Candidates - Quiver Quantitative
Larimar Therapeutics Raises $69M in Oversubscribed Public Offering - AInvest
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares - GlobeNewswire
Rare Disease Biotech Larimar Secures $69M Windfall as Investors Rush to Oversubscribed Stock Offering - Stock Titan
Using R and stats models for Larimar Therapeutics Inc. forecastingShort-Term AI-Based Stock Price Forecast - Newser
What recovery options are there for Larimar Therapeutics Inc.Free High Win Rate Trading Opportunities - Newser
What indicators show strength in Larimar Therapeutics Inc.Predictive System for Long-Term Stock Forecast - Newser
Is it time to cut losses on Larimar Therapeutics Inc.Conservative Entry for High Return Setup Backed - metal.it
Is Larimar Therapeutics Inc. stock overhyped or has real potentialFree Trade Setups With AI Powered Filters - Newser
Will Larimar Therapeutics Inc. Stock Benefit from AI and Green Energy TrendsReal Time Trade Opportunity Alerts Monitor Market Surges - metal.it
Larimar Therapeutics Announces Public Offering, Drops 20% in Share Price - AInvest
Larimar Therapeutics stock falls after $60 million public offering By Investing.com - Investing.com Canada
Larimar Therapeutics falls after $60 mln equity raise - TradingView
Multi asset correlation models including Larimar Therapeutics Inc.Free Breakout Momentum Picks With Protection - Newser
Larimar Therapeutics launches public offering of common stock - Investing.com India
Larimar Therapeutics Inc. Stock Support and Resistance Levels You Should KnowIntelligent Trade Forecast With AI Analytics - Newser
LRMR Stock Priced at Lower End of Predetermined Range - GuruFocus
Larimar Therapeutics Inc (LRMR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):